No innovations have ever had the magnitude of impact on everyday life as those pertaining to information technology and communication. As a result of their sophistication, endless amounts of data are readily available to us today, at any moment. Artificial Intelligence, making full use of this abundant resource, is a new technological tool sweeping through our world, promising to once again revolutionize our everyday lives. For that reason, it is of utmost importance that appropriate rules are adopted early on to foster innovation and trust in Artificial Intelligence, while ensuring respect for human rights and democratic values.
Intellectual property law in the European Union governs the creation and commercial exploitation of exclusive rights given by statutory law to a creator (or inventor). An EU Member State grants a creator a temporarily limited right – intellectual property right – to exclude others from any exercise of the protected intellectual property right as an incentive to promote creative works, innovation or to prevent market confusion. In other words, the main purpose why a state grants intellectual property rights stems from its pursuance of the above-mentioned public interest.
“Generally speaking,“ Tine Misic, Partner at ODI Law says, “the Slovenian market and the economy are doing well, our long-term debt has been upgraded to AA- by S&P, which means Slovenian bonds are highly ranked, and the GDP is growing at about 3.1%, [which is] relatively high compared to other EU countries.“
ODI Law in Slovenia and the LTA Legal Tax Audit firm in the Czech Republic have advised the Czech Ministry of Finance and IMOB and PRISKO, the Ministry's two state-owned subsidiaries, on the cross-border sale of a majority stake in VIPAP VIDEM KRSKO, the largest paper mill in Slovenia, as well as on the sale of claims against it, all to Czech-based RIDG Holding. RIDG was advised by Schoenherr.
Pharmaceutical products have been in the spotlight of the Council of the European Union’s Product Liability Directive since its adoption in 1985. Despite the amount of time that has passed, some legal uncertainties remain that strike directly at the notion of defectiveness, as well as the causal link between the defect and the damage (which proved to be even more important in the case of pharmaceutical products). Establishing such causal link in cases involving vaccines is notoriously difficult, especially from the perspective of a lay consumer. This has led some EU member states, such as France, to introduce case law aimed at facilitating the burden of proof in specific sectors.
Dentons has advised Slovenian state-owned Slovenski Drzavni Holding d.d., on the sale, made through private placement to institutional investors via an accelerated bookbuild process, of an aggregate of shares and global depository receipts representing 1,999,999 shares in Nova Ljubljanska Banka d.d. Ulcar & Partnerij advised the Republic of Slovenia on Slovenian law aspects and Shearman & Sterling reportedly advised the syndicate of banks, including Deutsche Bank as sole global coordinator and joint bookrunner with Citigroup. Wood & Company acted as Co-Lead Manager.